Home › Research › Topics › assessment
assessment
849 studies tagged assessment, dated 1982-05-01 to 2026-09-16. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Feasibility of remote self-administered cognitive assessment in an Alzheimer's disease treatment clinic 2026-09-16
- Structural brain imaging for newly diagnosed cognitive impairment by Medicare coverage type 2026-09-15
- Detection and Continuous Monitoring of Memory Dysfunction in Mild Cognitive Impairment and Healthy Aging Through Adaptive Computational Phenotyping 2026-09-12
Studies
849 studies carry this tag.
Date range
1982 to 2026
Top journals
- Neurology 63
- Journal of Alzheimer's disease : JAD 31
- Archives of neurology 30
- Alzheimer s & Dementia 25
- Alzheimer's & dementia : the journal of the Alzheimer's Association 21
316 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
The assessment and treatment of pain in persons with cognitive impairments pose unique challenges.
-
Patients with mild cognitive impairment (MCI) showed a high probability to be diagnosed with Alzheimer dementia (AD) after 30 months.
-
Data support the evidence that neuropsychological rehabilitation is effective in Alzheimer disease (AD), to strengthen the pharmacological treatment to delay the progression of dementia.
-
Adjusted estimates of MTA were associated with significantly increased risk of developing dementia within 3 years, suggesting that obtaining a magnetic resonance image during the evaluation of MCI may offer additional independent information about the risk of progression to dementia.
-
This report reviews the state of the literature and opportunities for research related to the cognitive correlates of functional status.
-
The merit of screening for dementia and cognitive impairment has been the subject of recent debate.
-
It has been assumed that each MCI subtype is associated with an increased risk for a particular type of dementia.
-
Persons with MCI also have impaired motor function, and the degree of impairment in lower extremity function is related to the risk of AD.
-
These results suggest that the SLUMS and MMSE have comparable sensitivities, specificities, and area under the curve in detecting dementia.
-
Further long-term studies are needed to examine the time-dependent evolution from mild cognitive impairment to dementia and to establish age-specific conversion rates during lifetime.
-
43/100
The NUCOG was undertaken with the MMSE on a total of 347 individuals, with 82 subjects in the control group and 265 in the patient group.
-
Subjective memory complaints (SMCs) are common in older people and are often thought to indicate cognitive impairment.
-
Human immunodeficiency virus (HIV)-associated cognitive impairment, a significant cause of morbidity, affects up to 30% of HIV-infected people.
-
Cortical thickness is a more reliable measure of atrophy than volume due to the low variability in the cytoarchitectural structure of the grey matter.
-
Structural and functional magnetic resonance imaging (fMRI) was performed on 21 healthy elderly controls, 14 subjects with mild cognitive impairment (MCI) and 15 patients with mild Alzheimer's disease (AD) to investigate changes in fMRI activation in relation to underlying structural atrophy.
-
The aim of this study was to establish the rate of progression from mild cognitive impairment (MCI) to dementia in patients with Parkinson's disease (PD).
-
The majority of patients with MCI progressed to dementia and a significant proportion died.
-
54/100
Different patterns of gray matter density distribution in patients with mild cognitive impairment may be associated to different rates of conversion to Alzheimer disease.
-
Magnetic resonance (MR)-based volume measurements of atrophy are potential markers of disease progression in patients with amnestic mild cognitive impairment (MCI) and Alzheimer's disease (AD).
-
Individuals with all types of mild cognitive impairment have an elevated risk of dementia over 3 years, more so in those with an APOE epsilon4 allele.
-
MCI involves more substantial cognitive and memory decline than normal aging and represents a significant risk factor for the development of dementia.
-
When the clinical syndrome of MCI evolves on a neurodegenerative basis, the multiple-domain type of MCI has a less favorable prognosis than the amnestic type and may represent a more advanced prodromal stage of dementia.
-
The neuropathologic substrate of amnestic mild cognitive impairment (aMCI) is not known.
-
53/100
The neuropathologic outcome of amnestic MCI following progression to dementia is heterogeneous, and it includes AD at a high frequency.
-
A heterogeneous community sample (n=371) of predominantly ethnic minority elderly assessed by standardized research protocol, 231 of whom met criteria for dementia or mild cognitive impairment (MCI).
-
64/100
Mild cognitive impairment is a syndrome defined as cognitive decline greater than expected for an individual's age and education level but that does not interfere notably with activities of daily life.
-
There is a substantial body of literature dealing with predictors of dementia in patients with MCI.
-
Mild cognitive impairment (MCI) was proposed as a nosological entity referring to elderly people with mild cognitive deficit but no dementia.
-
The results demonstrate that functional connectivity can be an effective marker for the detection of changes in brain function in MCI subjects.
-
50/100
The impact of cognitive impairment on activities of daily living (ADL) is being used as a major criterion for differentiating between mild cognitive impairment (MCI) and dementia.
-
Mild Cognitive Impairment (MCI) is a borderline state between age-associated cognitive decline and mild dementia.
-
Although the clinical course of Alzheimer disease (AD) is gradual, it is useful for a number of reasons to distinguish between different levels of severity.
-
Elderly people taking anticholinergic drugs had significant deficits in cognitive functioning and were highly likely to be classified as mildly cognitively impaired, although not at increased risk for dementia.
-
Cognitive impairment and late-life depression are associated with increased risk for subsequent dementia; however, investigations of these phenomena appear to be proceeding along separate tracks.
-
Patients with MCI showed no significant difference (P>.05) in the number of diffuse plaques from that in normal controls or patients with EAD.
-
These data provide evidence for clinical and functional heterogeneity among subjects with aMCI and suggest that 18FDG-PET findings combined with memory scores may be useful in predicting short-term conversion to AD.
-
When proper normative values are used, only age and education, and not race or ethnicity, are associated with higher frequency of MCI.
-
MCI was prevalent in 24.7% of participants at baseline.
-
Mild cognitive impairment (MCI) has been considered a transitional state between normal aging and dementia, characterised by memory impairment but normal general cognitive functioning.
-
57/100
During follow-up, 13 healthy patients converted to MCI or Alzheimer disease (AD), whereas 39 MCI subjects converted to AD.
-
Although there may be some mild functional changes associated particularly with the MCI-memory impaired subtype, individuals with MCI do not appear to under-report their functional status as can often been seen in persons with dementia.
-
Mild cognitive impairment (MCI) represents a transitional state between normal aging and dementia.
-
The diagnosis of Alzheimer's disease (AD) in patients with mild cognitive impairment (MCI) is limited because it is based on non-specific behavioral and neuroimaging findings.
-
A variety of clinically-defined predementia syndromes, with differing diagnostic criteria and nomenclature, have been proposed to describe nondisabling symptomatic cognitive deficits arising in elderly persons.
-
43/100
Mild cognitive impairment (MCI) describes a state of cognitive functioning that is below defined norms, yet falls short of dementia in severity.
-
These data confirm the presence of cognitive impairment in 50% of patients with ALS and particularly implicate executive dysfunction and mild memory decline in the disease process.
-
CERAD total scores were obtained by summing scores from the individual CERAD subtests (excluding the Mini-Mental State Examination [MMSE]) into a total composite (maximum score = 100).
-
While the Mini-Mental State Examination (MMSE) was originally developed to screen for dementia and delirium, many neurologists use this measure as a screening instrument for 'cognitive impairment' in hospitalized stroke patients.
-
Inflammatory mechanisms have been implicated in Alzheimer's disease (AD) and might be mediated via the COX-2 enzyme.
-
It is well established that oxidative stress plays a key role in the degenerative neuronal death and progression of Alzheimer's disease (AD), although it is not clear if it is the primary triggering event in the pathogenesis of this disorder.
From across this tag
9 of the 848 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 9. The same 9 appear here every time.
- Improved dementia screening for elderly with low education in South Korea using the Cognitive Impairment Screening Test (CIST)
- Neighborhood Deprivation, Subjective and Objective Cognitive Impairment
- Promoting Brain Health in the Context of Normal Aging and Mild Cognitive Impairment: A Tutorial
- Retinal alterations in mild cognitive impairment and Alzheimer's disease: an optical coherence tomography study
- Population‐Based Norms for the Montreal Cognitive Assessment in Arab Adults
- Early Alzheimer’s disease (mild cognitive impairment or mild dementia): Prevalence, diagnostics, treatment options, and guidelines in Asia, Australasia, and Pacific nations countries
- Five-year outcomes after IVIG for mild cognitive impairment due to alzheimer disease
- Frailty and cognitive impairment--a review of the evidence and causal mechanisms
- Estimating cognitive function score from mild cognitive impairment to moderate dementia using a hybrid model combining plasma biomarkers with electroencephalogram signal